Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Schweiger, Thomas ^a   Nikolowsky, Christoph ^a   Starlinger, Patrick ^a   Traxler, Denise ^a   Zimmermann, Matthias ^a   Birner, Peter ^a   Hegedüs, Balazs ^a,b,c   Dome, Balazs ^a,d,e   Bergmann, Michael ^a   Mildner, Michael ^f   Klepetko, Walter ^a   Hoetzenecker, Konrad ^a   Ankersmit, Hendrik Jan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

^e NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^f Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; HEAT SHOCK PROTEIN 27; VIMENTIN; ACTA2 PROTEIN, HUMAN; ACTIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAPILLARY DENSITY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENCE FREE SURVIVAL; STROMA CELL; UPREGULATION; CANCER STAGING; COLORECTAL TUMOR; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; VERY ELDERLY;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HSP27 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STROMAL CELLS; VIMENTIN;

EID: 84925652386     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120724     Document Type: Article

References (46)

1. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 1323-1360. doi: 10.1093/annonc/mdp530 PMID: 19948741
2. Malvezzi M, Arfe A, Bertuccio P, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2011. Ann Oncol 2011; 22: 947-956. doi: 10.1093/annonc/mdq774 PMID: 21303801
3. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007; 101: 805-815. PMID: 17226777
4. Smith NR, Baker D, Farren M, Pommier A, Swann R, et al. Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy. Clin Cancer Res 2013; 19: 6943-6956. doi: 10.1158/1078-0432.CCR-13-1637 PMID: 24030704
5. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322. doi: 10.1016/j.ccr.2012.02.022 PMID: 22439926
6. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659. PMID: 3537791
7. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, et al. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 2001; 7: 3097-3105. PMID: 11595701
8. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW Jr, et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004; 23: 7366-7377. PMID: 15326482
9. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, et al. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One 2012; 7: e30219. doi: 10.1371/journal.pone.0030219 PMID: 22291919
10. Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 2007; 13: 1736-1741. PMID: 17363526
11. Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer 2007; 96: 986-992. PMID: 17325702
12. Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007; 13: 2082-2090. PMID: 17404090
13. Torres S, Bartolome RA, Mendes M, Barderas R, Fernandez-Acenero MJ, et al. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 2013; 19: 6006-6019. doi: 10.1158/1078-0432.CCR-13-1130 PMID: 24025712
14. Herrera M, Islam AB, Herrera A, Martin P, Garcia V, et al. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res 2013; 19: 5914-5926. doi: 10.1158/1078-0432.CCR-13-0694 PMID: 24052018
15. Hirano S, Rees RS, Gilmont RR. MAP kinase pathways involving hsp27 regulate fibroblast-mediated wound contraction. J Surg Res 2002; 102: 77-84. PMID: 11796002
16. Hirano S, Shelden EA, Gilmont RR. HSP27 regulates fibroblast adhesion, motility, and matrix contraction. Cell Stress Chaperones 2004; 9: 29-37. PMID: 15270075
17. Suarez E, Syed F, Alonso-Rasgado T, Mandal P, Bayat A. Up-regulation of tension-related proteins in keloids: knockdown of Hsp27, alpha2beta1-integrin, and PAI-2 shows convincing reduction of extracellular matrix production. Plastic and reconstructive surgery 2013; 131: 158e-173e. doi: 10.1097/PRS.0b013e3182789b2b PMID: 23358011
18. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, et al. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999; 274: 24211-24219. PMID: 10446196
19. Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, et al. p38 inhibitors prevent TGF-beta- induced myofibroblast transdifferentiation in human tenon fibroblasts. Investigative ophthalmology & visual science 2006; 47: 1500-1509.
20. Piotrowicz RS, Hickey E, Levin EG. Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 1998; 12: 1481-1490.
21. Wettstein G, Bellaye PS, Kolb M, Hammann A, Crestani B, et al. Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2013; 27: 1549-1560. doi: 10.1096/fj.12-220053 PMID: 23288928
22. Thuringer D, Jego G, Wettstein G, Terrier O, Cronier L, et al. Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2013; 27: 4169-4183. doi: 10.1096/fj.12-226977 PMID: 23804239
23. Lofdahl M, Kaarteenaho R, Lappi-Blanco E, Tornling G, Skold MC. Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respir Res 2011; 12: 48. doi: 10.1186/1465-9921-12-48 PMID: 21496259
24. Jan Ankersmit H, Nickl S, Hoeltl E, Toepker M, Lambers C, et al. Increased serum levels of HSP27 as a marker for incipient chronic obstructive pulmonary disease in young smokers. Respiration 2012; 83: 391-399. doi: 10.1159/000336557 PMID: 22469636
25. Hacker S, Lambers C, Hoetzenecker K, Pollreisz A, Aigner C, et al. Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. Clinical laboratory 2009; 55: 31-40. PMID: 19350847
26. Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, et al. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta 2012; 413: 1115-1120. doi: 10.1016/j.cca.2012.03.008 PMID: 22465083
27. Schweiger T, Hegedus B, Nikolowsky C, Hegedus Z, Szirtes I, et al. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study. Ann Surg Oncol 2014; 21: 946-954. doi: 10.1245/s10434-013-3386-7 PMID: 24281417
28. Schweiger T, Kollmann D, Nikolowsky C, Traxler D, Guenova E, et al. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking. Eur J Cardiothorac Surg 2013.
29. Driessen A, Landuyt W, Pastorekova S, Moons J, Goethals L, et al. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas. Ann Surg 2006; 243: 334-340. PMID: 16495697
30. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-1887. PMID: 1281237
31. Yeung TM, Buskens C, Wang LM, Mortensen NJ, Bodmer WF. Myofibroblast activation in colorectal cancer lymph node metastases. Br J Cancer 2013; 108: 2106-2115. doi: 10.1038/bjc.2013.209 PMID: 23652304
32. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401. PMID: 16572188
33. Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, et al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumour Biol 2013; 34: 1013-1020. doi: 10.1007/s13277-012-0638-2 PMID: 23328994
34. Yoshimura T, Nagahara M, Kuo C, Turner RR, Soon-Shiong P, et al. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment. Epigenetics: official journal of the DNA Methylation Society 2011; 6: 1001-1011. doi: 10.4161/epi.6.8.16063 PMID: 21725199
35. Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, et al. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut 2010; 59: 1501-1510. doi: 10.1136/gut.2009.196626 PMID: 20947885
36. Ghosh A, Lai C, McDonald S, Suraweera N, Sengupta N, et al. HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53. Exp Mol Pathol 2013; 94: 103-108. doi: 10.1016/j.yexmp.2012.09.001 PMID: 22982087
37. Wang F, Zhang P, Shi C, Yang Y, Qin H. Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer. Med Oncol 2012; 29: 1780-1788. doi: 10. 1007/s12032-011-0037-3 PMID: 21861207
38. Yu Z, Zhi J, Peng X, Zhong X, Xu A. Clinical significance of HSP27 expression in colorectal cancer. Molecular medicine reports 2010; 3: 953-958. doi: 10.3892/mmr.2010.372 PMID: 21472339
39. Kahlert C, Pecqueux M, Halama N, Dienemann H, Muley T, et al. Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases. Br J Cancer 2014; 110: 441-449. doi: 10.1038/bjc.2013.745 PMID: 24292449
40. Sato T, Miwa A. Ets-1 and integrin beta3 for lung metastasis from colorectal cancer. Apmis 2002; 110: 347-353. PMID: 12076271
41. Bosman JD, Yehiely F, Evans JR, Cryns VL. Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer. Breast Cancer Res Treat 2010; 119: 63-70. doi: 10.1007/s10549-009-0330-4 PMID: 19205872
42. Zhao M, Ding JX, Zeng K, Zhao J, Shen F, et al. Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer? Tumour Biol 2014; 35: 1051-1056. doi: 10.1007/s13277-013-1139-7 PMID: 24061637
43. Urosevic J, Garcia-Albeniz X, Planet E, Real S, Cespedes MV, et al. Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nature cell biology 2014; 16: 685-694. doi: 10.1038/ncb2977 PMID: 24880666
44. Schweiger T, Lang G, Klepetko W, Hoetzenecker K. Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers. Eur J Cardiothorac Surg 2014; 45: 408-416. doi: 10.1093/ejcts/ezt288 PMID: 23729747
45. Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, et al. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer. BJU Int 2008; 102: 610-616. doi: 10.1111/j.1464-410X.2008.07669.x PMID: 18384625
46. Oncogenex Corp. Apatorsen (OGX-427). 2014. Available: http://www.oncogenex.com/apatorsen-ogx-427.